Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Revolution Medicines (RVMD) over the last 6 years, with Q3 2025 value amounting to 0.0.

  • Revolution Medicines' Asset Utilization Ratio fell 127496.6% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 127496.6%. This contributed to the annual value of 0.01 for FY2023, which is 8234.66% down from last year.
  • As of Q3 2025, Revolution Medicines' Asset Utilization Ratio stood at 0.0, which was down 127496.6% from 0.0 recorded in Q3 2024.
  • Revolution Medicines' 5-year Asset Utilization Ratio high stood at 0.06 for Q1 2021, and its period low was 0.0 during Q3 2025.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.04 (2022), whereas its average is 0.03.
  • As far as peak fluctuations go, Revolution Medicines' Asset Utilization Ratio soared by 826.27% in 2022, and later plummeted by 127496.6% in 2025.
  • Over the past 5 years, Revolution Medicines' Asset Utilization Ratio (Quarter) stood at 0.04 in 2021, then grew by 8.26% to 0.04 in 2022, then crashed by 82.4% to 0.01 in 2023, then crashed by 94.54% to 0.0 in 2024, then plummeted by 1274.97% to 0.0 in 2025.
  • Its Asset Utilization Ratio stands at 0.0 for Q3 2025, versus 0.0 for Q3 2024 and 0.0 for Q2 2024.